Learn More
Selleck Chemical LLC Praluzatamab ravtansine-1MG-5

Supplier: Selleck Chemical LLC D40391MG5
Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4 with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.